CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-11-12 | HEALY JAMES Director | Conversion | +1,846,890 | 1,981,863 | ||
| 2014-11-12 | HEALY JAMES Director | Conversion | +149,970 | 2,131,833 | ||
| 2014-11-12 | HEALY JAMES Director | Purchase | +425,926 | $13.50 | $5.8M | 2,557,759 |
| 2014-11-12 | HEALY JAMES Director | Conversion · Series B Preferred Stock | −47 | 0 | ||
| 2014-11-12 | HEALY JAMES Director | Conversion · Series B Preferred Stock | −1,846,890 | 0 | ||
| 2014-11-12 | HEALY JAMES Director | Conversion · Series C Preferred Stock | −149,970 | 0 | ||
| 2014-11-12 | Daiichi Sankyo Company, LTD Former 10% Owner | Conversion | +2,867,426 | 2,867,426 | ||
| 2014-11-12 | Daiichi Sankyo Company, LTD Former 10% Owner | Conversion · Series B Preferred Stock | −2,867,426 | 0 | ||
| 2014-11-12 | Richards Christos Director | Option exercise | +26,505 | $1.67 | $44K | 26,505 |
| 2014-11-12 | Richards Christos Director | Other disposition | −2,956 | 23,549 | ||
| 2014-11-12 | Richards Christos Director | Conversion | +39,991 | 63,540 | ||
| 2014-11-12 | Richards Christos Director | Conversion | +12,672 | 76,212 | ||
| 2014-11-12 | Richards Christos Director | Conversion | +2,624 | 78,836 | ||
| 2014-11-12 | Richards Christos Director | Option exercise · Warrant to Purchase Common Stock | −26,505 | 0 | ||
| 2014-11-12 | Richards Christos Director | Option exercise · Warrant to Purchase Series B Preferred Stock | −429 | 0 | ||
| 2014-11-12 | Richards Christos Director | Option exercise · Series B Preferred Stock | +429 | $0.02 | $7 | 12,673 |
| 2014-11-12 | Richards Christos Director | Other disposition · Series B Preferred Stock | −1 | 12,672 | ||
| 2014-11-12 | Richards Christos Director | Conversion · Series A Preferred Stock | −39,991 | 0 | ||
| 2014-11-12 | Richards Christos Director | Conversion · Series B Preferred Stock | −12,672 | 0 | ||
| 2014-11-12 | Richards Christos Director | Conversion · Series C Preferred Stock | −2,624 | 0 |
Page 36 of 39 · 768 trades